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Abstract
 
In B lymphocytes, immunoglobulin (Ig)M receptors drive development and construction of
naive repertoire, whereas IgG receptors promote formation of the memory B cell compart-
ment. This isotype switching process requires appropriate B cell activation and T cell help. In
the absence of T cell help, activated B cells undergo Fas-mediated apoptosis, a peripheral
mechanism contributing to the establishment of self-tolerance. Using Ig
 
 
 
-deficient 
 
 
 
MT
mouse model, where B cell development is blocked at pro-B stage, here we show an alternative
developmental pathway used by isotype-switched B cell precursors. We find that isotype
switching occurs normally in B cell precursors and is T independent. Ongoing isotype switching
was found in both normal and 
 
 
 
MT B cell development as reflected by detection of IgG1 germline
and postswitch transcripts as well as activation-induced cytidine deaminase expression, resulting
in the generation of IgG-expressing cells. These isotype-switched B cells are negatively selected
by Fas pathway, as blocking the Fas/FasL interaction rescues the development of isotype-
switched B cells in vivo and in vitro. Similar to memory B cells, isotype-switched B cells have
a marginal zone phenotype. We suggest a novel developmental pathway used by isotype-
switched B cell precursors that effectively circumvents peripheral tolerance requirements. This
developmental pathway, however, is strictly controlled by Fas/FasL interaction to prevent B
cell autoimmunity.
Key words: lymphopoiesis • B cell antigen receptor • immune tolerance •
apoptosis • autoimmunity
 
Introduction
 
B cell development compartmentalizes processes of generation
and selection from memory formation, not only by ana-
tomical sites but also with various phenotypic changes
(1–3). Perhaps the most significant and irreversible changes
are applied to the B cell antigen receptor (BCR) before enter-
ing the memory compartment. Throughout a T cell–dependent
process and selection, IgM-expressing B cells undergo somatic
mutation and isotype switching to express, in most cases,
IgG receptor with increased affinity to the antigen. Some
of these cells differentiate into memory B cells and give rise
to a high affinity antigen-specific repertoire (for review see
references 1, 2, 4, and 5). Thus, although Ig
 
  
 
is preferen-
tially used for B cell development in the BM, Ig
 
  
 
isotypic
receptors are associated with formation of the memory
compartment (3, 6), whereas Ig
 
 
 
-expressing memory B
cells have been described in human and mouse (7, 8).
Maturation of B cells to the periphery is limited by autoim-
munity in the BM (9, 10) and subsequent positive selection
mediated by BCR signaling (11–14). In the periphery, B
cell activation depends on T cell help and positive selection
of high affinity clones promotes development into the
memory compartment, a process also associated with iso-
typic changes in the BCR (1, 5, 15). In contrast, lack of T
cell help results in Fas-mediated apoptosis, a peripheral
mechanism thought to eliminate autoreactive newly
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Abbreviations used in this paper:
 
 AID, activation-induced cytidine deami-
nase; BCR, B cell antigen receptor; H, heavy; MZ, marginal zone; Tg,
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formed B cells, and B cells acquiring self-reactivity by so-
matic mutations during the germinal center reaction (1,
16–19), a paradigm also called “the second window of tol-
erance” (18). Hence, peripheral activation and the Fas
pathway are important in controlling B cell autoimmunity
(16, 20–22) and preventing the generation of an autoim-
mune memory repertoire (23). In contrast, sensitized hu-
man memory B cells undergo Fas-independent apoptosis
(24). This may suggest that B cell development also com-
partmentalizes tolerance requirements in Ig
 
 
 
-developing
and -mature B cells from an isotype-switched non-Ig
 
 
 
memory compartment.
The requirement of functional 
 
  
 
heavy (H) expression
and signaling in promoting B cell development has been
shown in several models of mutated mice (13, 25). It is also
supported by studies showing that IgG or 
 
 
 
H chains fail, in
general, to promote B cell development in transgenic (Tg)
mice (for review see reference 6). Nevertheless, the process
of isotype switching in BM development has not been
studied yet. In many 
 
 
 
H Tg mice, despite the efficient al-
lelic exclusion mediated by the Tg 
 
 
 
H, IgG-expressing B
cells are generated, resulting in production of serum IgG
(26, 27). Interestingly, lack of Fas in these 
 
 
 
H Tg mice
generates an autoimmune IgG repertoire (26). These stud-
ies may suggest that isotype switching can occur in BM de-
velopment, although this is difficult to prove in these mice.
Hence, 
 
 
 
H-driven repertoire may have differential roles in
terms of B cell development and tolerance requirements. In
this study we use mice lacking the IgM transmembrane tail
exons (
 
 
 
MT), in which B cell development is blocked at
the pro-B stage (28), to show a novel developmental path-
way used by isotype-switched B cell precursors that is T
cell independent. These B cells circumvent the peripheral
activation requirement and develop directly into the mem-
ory compartment. This developmental pathway is tightly
controlled by Fas/FasL interaction to prevent B cell au-
toimmunity. Therefore, we propose that the Fas pathway
plays an important role in the establishment of tolerance
during BM development.
 
Materials and Methods
 
Mice.
 
Normal C57/BL6 (B6), C57/BL6-Fas
 
lpr
 
/Fas
 
lpr 
 
(B6/
lpr), C57/BL6-
 
 
 
MT/
 
 
 
MT (
 
 
 
MT), C57/B6-TCR
 
 
 
 
 
/
 
 
 
/
TCR
 
 
 
 
 
/
 
  
 
(TCR
 
 
 
 
 
/
 
 
 
/TCR
 
 
 
 
 
/
 
 
 
) mice were purchased from
The Jackson Laboratory. Mice carrying both 
 
lpr
 
 and 
 
 
 
MT ho-
mozygous mutations (
 
 
 
MT/lpr) were generated by crossing B6/
 
lpr
 
 and 
 
 
 
MT mice. Littermates were typed for 
 
 
 
MT and 
 
lpr
 
 by
PCR. To generate 
 
 
 
MT/lpr/TCR
 
 
 
 
 
/
 
 
 
/TCR
 
 
 
 
 
/
 
  
 
(four knock-
out) mice, 
 
 
 
MT/lpr mice were crossed with TCR
 
 
 
 
 
/
 
 
 
/
TCR
 
 
 
 
 
/
 
  
 
mice (29, 30). The progeny was screened by PCR
analysis to identify TCR
 
  
 
deficiency (primer sequences as pub-
lished by The Jackson Laboratory) and by flow cytometry to
identify TCR
 
  
 
deficiency. In some experiments 3-83
 
   
 
Tg mice
were used (31). All animals were kept under specific pathogen-
free conditions. All experiments were approved by the Technion
review board.
 
BM Cell Culture and Cell Sorting.
 
B cell precursors from nor-
mal, 
 
 
 
MT, and 
 
 
 
MT/
 
lpr
 
 mice were grown in vitro as previously
described (32). In brief, RBC-depleted BM cells were cultured at
a concentration of 2 
 
  
 
10
 
6 
 
cells/ml for 2–5 d in the presence of
50–100 U/ml rIL-7. Cells grown in these primary cultures were
used directly for cellular and molecular analysis. In some experi-
ments BM cells were depleted of Ig
 
  
 
cells using magnetic beads
(Miltenyi Biotec), and cells were labeled with CFSE (Molecular
Probes), washed, and incubated with IL-7 for 5 d. Cells were
then stained for surface markers and analyzed for CFSE labeling
by FACS
 
®
 
. In some experiments BM cells were cultured in the
presence of 2.5–5 
 
 
 
g/ml hamster anti–mouse Fas antibody (clone
Jo2; BD Biosciences) or 25–50 
 
 
 
g/ml recombinant FasIg (33). In
other experiments cultured B cells were stained with goat anti–
mouse 
 
 
 
-biotin (Southern Biotechnology Associates, Inc.) and
Ig
 
 
 
  
 
cells were sorted using streptavidin MACS microbeads
(Miltenyi Biotec). RNA samples from sorted cells were used for
RT-PCR. In some experiments B220
 
  
 
cells were sorted directly
from BM and spleen by magnetic beads and used for mRNA
preparation.
 
RT-PCR.
 
Total RNA was purified from cultured cells or
sorted Ig
 
 
 
  
 
cells. RNA samples were reverse transcribed to
cDNA and PCR amplified to detect Fas, FasL, and 
 
 
 
H chain ex-
pression and for G
 
 
 
S control as previously described (32). PCR
conditions for Fas were 30 s at 94
 
 
 
C, 30 s at 52
 
 
 
C, and 60 s at
72
 
 
 
C for 30 cycles. Primer sequences for Fas were: sense, 5
 
 
 
-
TGTCCTGCCTCTGGTGCT-3
 
 
 
; antisense, 5
 
 
 
-ACAACCAT-
AGGCGATTTCTGG-3
 
 
 
. PCR conditions for FasL were 30 s at
94
 
 
 
C, 60 s at 52
 
 
 
C, and 90 s at 72
 
 
 
C for 30 cycles. Primer se-
quences for FasL were: sense, 5
 
 
 
-CATGCAGCAGCCCGT-
GAATTACCC-3
 
 
 
; antisense, 5
 
 
 
-TTAAAGCTTATATAAGC-
CAAAAAAAGGT-3
 
 
 
. For detection of 
 
 
 
H chain expression we
used 5
 
  
 
oligo specific for VHJ558 family 5
 
 
 
-CGAGTCCTC-
CAG(AC)ACAGCCTACAT-3
 
 
 
 and 
 
 
 
CH1 5
 
 
 
-CGTGTCAG-
GCTAGCGGGTGTTGTTTTGGC-3
 
 
 
. PCR conditions for
 
 
 
H chain were: 30 s at 94
 
 
 
C, 30 s at 63
 
 
 
C, and 60 s at 72
 
 
 
C for
28 cycles. For detection of ongoing isotype switching we used
RT-PCR amplification for IgG germline and postswitch tran-
scripts as well as for activation-induced cytidine deaminase (AID).
To detect IgG germline transcripts we used primers at the I
 
 
 
1F
and constant-
 
 
 
1R or at I
 
 
 
2b and constant-
 
 
 
2bR. To detect IgG
postswitch transcripts we used primers at I
 
 
 
F and constant-
 
 
 
1R
or constant-
 
 
 
2bR. PCR conditions and primer sequencing were
as previously described (34).
 
Analysis of Serum Ig.
 
Titers of IgG in serum were determined
by sandwich ELISA using specific goat anti–mouse polyclonal re-
agents (Southern Biotechnology Associates, Inc.). Purified IgG
was used for the standard curve and for calculation of Ab concen-
tration. In some experiments serum samples were analyzed by
SDS-PAGE on a 10% gel. After transfer to nitrocellulose, mem-
brane blots were blocked with 5% milk and detected using goat
anti–mouse IgG (
 
  
 
chain–specific) biotinylated antibody (South-
ern Biotechnology Associates, Inc.), followed by streptavidin
horseradish peroxidase. Visualization of specific bands was per-
formed by enhanced chemiluminescence reagent.
 
ELISPOT.
 
Detection of Ab-forming cells by ELISPOT as-
say was performed as previously described (35). In brief, nitrocel-
lulose filters were placed in 5 ml tissue culture Petri dishes and
coated with a mix of 2.5 
 
 
 
g/ml goat anti–mouse 
 
  
 
and goat anti–
mouse 
 
  
 
(Southern Biotechnology Associates, Inc.). Filters were
then washed (0.1% Tween 20/PBS) and blocked with 5% BSA.
Before adding the cells, filters were washed twice with PBS and
twice with IMDM (GIBCO BRL). RBC-depleted splenocytes
were resuspended in IMDM and cultured on top of filters for 12–
16 h. After incubation, filters were extensively washed and incu-T
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bated with goat anti–mouse IgG (
 
  
 
chain–specific) biotinylated
Ab. Streptavidin conjugated with horseradish peroxidase was used
as a secondary probe and signals were generated by the enhanced
chemiluminescence reaction.
 
Flow Cytometry.
 
Single cell suspension from spleen or BM
cultures were stained for surface marker expression using FITC-,
PE-, and biotin-conjugated Abs, visualized with streptavidin Tri-
Color (Caltag Laboratories). Abs  used for cell staining were:
CD19, clone 1D3; CD21, clone 7G6; Fas, clone Jo2; TCR ,
clone H57 (all from BD Biosciences); CD23, clone 2G8; B220,
clone RA3-6B2; CD5, clone B19.1; goat anti–mouse   and goat
anti–mouse   (all from Southern Biotechnology Associates, Inc.).
Data for three-color analysis were collected on a FACSCalibur™
and analyzed using CELLQuest™ software (Becton Dickinson).
For all analysis forward and side scatter gates were set to include
viable cells and exclude dead cells and debris.
Preparation, Microencapsulation, and Injection of FasIg. FasIg-
transfected 3T3 cells engineered to secrete a recombinant form of
mouse Fas ligated to human Fc were provided by P. Leder (Har-
vard Medical School, Boston, MA; reference 33). Recombinant
soluble FasIg was purified from cell culture using conventional
protein-A column. The eluted FasIg was tested by flow cytome-
try for its ability to interact with membrane FasL on D4 cells
(provided by A. Marshak-Rothstein, Boston University, Boston,
MA) and inhibit T cell apoptosis in vitro (33). Soluble FasIg was
directly added to BM cultures as described above, or microencap-
sulated for injection into mice. FasIg-loaded Poly(dl-lactide-
coglycolide) PLGA microcapsules were prepared using the dou-
ble emulsion solvent extraction method as previously described
(36). The average concentration of FasIg release from 10 mg mi-
crocapsules in culture medium in vitro was 10   1.5 ng/ml/day.
Microcapsules were resuspended in sterile PBS and administered
to  MT mice by intramuscular injection of 10 mg/mouse (in 100
 l PBS). The first injection was at 2 wk old. Mice were injected
with the same dose every 10 d for a period of 40 d (an additional
four injections). 2 wk after the last injection the mice were killed
for analysis.
Results
Isotype Switching Rescues the Development of  MT B Cells
Expressing a Marginal Zone (MZ) Phenotype in Fas-deficient
Mice. In  MT mice, B cell development is blocked at the
pro-B stage (28) and essentially no serum Abs are pro-
duced. However, as we previously showed, lack of Fas res-
cues a significant development of isotype-switched B cells
and non-IgM serum Ab production (37). Most of these
cells expressed   (68%; Fig. 1 A) and underwent isotype
switching, as indicated by surface staining for  H chain
(Fig. 1 B). Despite the small number of mature B cells,
these mice developed serum IgG titers and IgG Ab-form-
Figure 1. Lack of Fas rescues development of isotype-switched B cells
in  MT mice. (A) Spleen cells from normal,  MT/lpr, and  MT mice
were stained for CD19, B220, and  . Analysis for   expression was per-
formed on gated B220 /CD19  cells. (B) Surface expression of IgG.
Spleen cells from the indicated mice were stained for CD19, B220, and
IgG. Gated B220 /CD19  cells were analyzed for IgG expression. (C)
Serum IgG and frequency of IgG-producing cells in the indicated mice.
Serum samples were collected from mice at 8–12 wk old, and titers of
IgG (left) were determined by ELISA. Results shown as mean   SEM of
at least five mice in each group. Numbers of IgG-producing cells (right)
were determined by ELISPOT assay and are expressed as frequency of
IgG-producing cells per 106 spleen cells. Results are mean   SEM of at
least five mice in each group.
Figure 2. Accumulation of isotype-switched B cells in MZ of spleen in
 MT/lpr mice. (A) Spleen cells from normal and  MT/lpr mice were
stained for CD21, CD23, and  . FACS® analysis for expression of CD21
and CD23 was performed on gated    cells. (B) Absolute numbers of
newly formed (CD21lo/CD23 ), follicular (CD21 /CD23 ), and MZ
(CD21 /CD23 ). Results are mean   SEM of three mice in each group.
(C) FACS® analysis for CD5 expression in gated CD19 /   spleen cells
from the indicated mice.T
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ing cells that were significantly higher than those of normal
mice (Fig. 1 C).
Because the development of mature B cells in  MT/lpr
mice is abnormal and characterized by an autoimmune re-
activity (37), we analyzed B cell populations in spleen. To
distinguish between the newly formed (CD21lo/CD23 ),
follicular (CD21 /CD23 ), and MZ (CD21 /CD23 ) B
cell populations, splenic B cells were stained with antibod-
ies to CD21 and CD23, as previously described (3, 11, 38).
The results showed a significant increase of 6–10-fold in
the relative size of B cells expressing the MZ phenotype in
 MT/lpr mice (Fig. 2 A). Absolute number analysis re-
vealed that 25–30% of    cells in  MT/lpr mice were MZ
B cells compared with 3–5% in normal mice (Fig. 2 B).
Further analysis revealed that most    cells in  MT/lpr
mice were B2 cells, as they did not express CD5 (Fig. 2 C).
We conclude that isotype-switched B cells developing in
 MT/lpr mice accumulate in the MZ compartment.
Lack of FasL Allows Development of Isotype-switched  MT
B Cells In Vitro. The generation of mature B cells in
 MT/lpr mice suggests that Fas has a direct role in nega-
tive selection of isotype-switched B cells. This hypothesis
predicts that isotype switching occurs in  MT and normal
mice but such cells are deleted by Fas-dependent mecha-
nisms. To test this hypothesis, we used our IL-7–driven
BM culture system. Surface staining revealed that 15–20%
of developing  MT and normal B cells in culture ex-
pressed Fas receptor (Fig. 3, A and B), thereby supporting a
few earlier studies showing Fas expression in developing B
cells in vivo (39, 40). As expected, functional Fas expres-
sion was not detectable in  MT/lpr cultures (Fig. 3 B). In
contrast, FasL expression could not be detected in either
culture, probably due to the lack of T cells, which are the
major source of FasL (Fig. 3 B).
The possibility that lack of FasL would allow develop-
ment of isotype-switched  MT B cells was directly tested
by cell staining. Strikingly, we found a significant popula-
tion of 1.5–2.5%  -expressing B cells in  MT BM cultures
(Fig. 3 C, top). Further surface staining for IgG revealed
the development of 1–2% of isotype-switched B cells in the
 MT cultures (Fig. 3 C, bottom). These cells are B220 /
CD43  (not depicted), suggesting that they progressed to
the Ig  immature stage. To confirm these results,  -express-
ing cells were sorted by magnetic beads and mRNA sam-
ples were subjected to RT-PCR amplification using oligo-
nucleotides specific for VHJ558 and the first five amino
acids of the  CH1 regions (AKTTP). As shown in Fig. 3
D, the expression of  H chain was evident in  MT cul-
tures. Importantly,  H could also be detected in normal
BM cultures, implicating the biological relevance of isotype
switching to normal B cell development. In control cul-
tures of 3–83   Tg mice,  H expression was not detect-
able by surface staining (Fig. 3 C, bottom) or by RT-PCR
(Fig. 3 D). To confirm that the IgG/ -expressing cells in
Figure 3. Lack of FasL allows develop-
ment of isotype-switched B cell precursors
in vitro. BM cells from normal and
 MT mice were cultured for 5 d in the
presence of IL-7. (A) Cells grown in
culture were stained for B220 and Fas
receptor and analyzed by FACS®. Expres-
sion of Fas was determined in gated
B220   cells. (B) RNA samples from
normal  MT and  MT/lpr BM cultures
were analyzed by RT-PCR for Fas and
FasL gene expression and for G s internal
control. Thymus RNA sample was used
for positive control. In  MT/lpr sample,
no product was observed in the PCR
for Fas because oligonucleotides used
flank the deleted DNA fragment that is
found in lpr mice. (C) Surface expression
of   and IgG in BM cultures. BM cells
from normal,  MT, and 3-83    Tg
mice were cultured in vitro, and cells
were stained for B220, CD19,  , and
IgG. Analysis for   (top) and surface IgG
expression was performed on 5,000
gated B220  cells. (D) RT-PCR ampli-
fication for detection of  H expression
in BM cultures.  -expressing cells from
the indicated BM cultures were sorted
using magnetic beads. mRNA samples
from the sorted cells were subjected to
RT-PCR amplification using oligonucleotides specific for VHJ558 and  CH1. mRNA from IgG-producing hybridoma was used as control. (E) Normal
BM cells were depleted of Ig  cells using magnetic beads, labeled with CFSE on day 0, washed, and cultured for 5 d with IL-7. Cells were stained
and analyzed for IgG and   coexpression on days 0 and 5 (top). Cells grown in the culture were stained for B220 and IgG and analyzed for CFSE
fluorescence (bottom). Analysis was performed on gated B220  cells (left), B220 /IgG  cells (middle), or B220  cells (right). Results are representative
of three different experiments.T
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the normal cultures are not residual memory or plasma cells
that may populate the BM, Ig  cells were depleted and cells
were labeled with CFSE, washed, and cultured in vitro for
5 d. Cells were then analyzed for   and IgG coexpression
(Fig. 3 E, top) and CFSE fluorescence (Fig. 3 E, bottom).
The results clearly show that no IgG/ -expressing cells are
present at the initiation of the cultures, but a significant
population of 2% is evident on day 5. These cells are prob-
ably culture derived, as they have minimal CFSE fluores-
cence as the total B220  cells in the culture (Fig. 3 E, bot-
tom, compare left to middle), due to multiple divisions
during the culture period. In contrast, the nondividing
B220  cells present in the culture, which are B220 , are
stained for CFSE and correspond to the initial labeling (Fig.
3 E, bottom right). These results suggest that isotype
switching occurs during BM development of  MT and
normal mice, and that maturation of switched B cells is
controlled by Fas/FasL pathway.
Detection of Ongoing Isotype Switching in  MT and Normal
BM Cultures and in BM In Vivo. To directly confirm that
isotype switching occurs during normal and  MT B cell
development in vitro, we used RT-PCR amplification for
well-described markers indicating ongoing isotype switch-
ing such as IgG germline and postswitch transcripts and ex-
pression of AID, as previously described (34). The results in
Fig. 4 A clearly show detection of all three markers that in-
dicate ongoing isotype switching in BM cultures of normal
and  MT mice. Thus, AID is significantly expressed in de-
veloping B cells and detection of IgG1 germline transcript
suggests that these loci are accessible for recombination.
The detection of IgG1 postswitch transcript implicates that
isotype switching does occur in both the normal and the
 MT cultures. These markers were undetected in control
mature splenic B cells but were induced in these cells upon
LPS treatment as has been shown (34), thereby indicating
the specificity of the assay.
To confirm for the biological relevance, ongoing isotype
switching was tested in B220  cells sorted directly from
 MT and normal BM or spleen. We found low but signif-
icant expression of AID and IgG2b germline transcript in
both  MT and normal BM, but not in spleen B cells, sug-
gesting that this spontaneous isotype switching is restricted
to the BM. We were able to find detectable expression of
IgG2b postswitch transcript only in normal BM B cells.
This may result from increased frequency of isotype
switching in normal BM as also reflected in our BM cul-
tures (about twofold more IgG-expressing cells shown in
Fig. 3 C, and increased levels of isotype switching markers
shown in Fig. 4 A). These results confirm that isotype
switching is an ongoing process during normal and  MT B
cell development in BM cultures and in the BM in vivo,
resulting in the expression of IgG BCR shown in Fig. 3.
Isotype-switched B Cell Precursors Are Eliminated by Fas/
FasL Pathway. To test whether isotype-switched B cell
precursors are eliminated by Fas-dependent mechanisms,
we treated cultured cells with anti-Fas antibodies during
the last 48 h of culture. In these experiments we followed
the appearance and/or disappearance of  -expressing cells
Figure 4. Ongoing isotype switching in normal and  MT BM cultures
and BM in vivo. (A) BM cells from normal and  MT mouse were cultured
in vitro for 5 d in the presence of IL-7. mRNA samples from the cultured
cells were subjected to RT-PCR amplification for IgG1 germline and
postswitch transcript as well as for AID expression. Normal splenic cells
either unstimulated or stimulated with LPS were used as negative and
positive controls, respectively. The results shown are representative of
three to five different experiments and a total of five to eight mice in each
group. (B) B220  cells were sorted directly from BM or spleen of the
indicated mice and mRNA samples were subjected to RT-PCR amplifi-
cation for AID and IgG2b germline and postswitch transcripts. Represen-
tative blots from three mice in each group are shown.
Figure 5. Fas receptor ligation eliminates Isotype-switched B cell pre-
cursors in vitro. BM cells from  MT and  MT/lpr mice were cultured
for a total of 5 d in the presence of IL-7. During the last 48 h, cultured
cells were treated with 25  g/ml FasIg or 2.5  g/ml anti-Fas antibodies.
Cultured cells were stained for CD19, B220, and  . FACS® analysis was
gated to viable CD19  cells. The plots shown are representative of three
different experiments.T
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using monoclonal reagents to ensure specificity of the stain-
ing. The results in Fig. 5 clearly show the appearance of a
significant population of 1.5–2% of isotype-switched   
cells (average of three experiments, 1.7   0.4) in both
 MT and  MT/lpr cultures (Fig. 5, top). However, upon
addition of anti-Fas antibodies, the    B cell population
was significantly reduced in  MT cultures by five- to six-
fold, and only 0.3%    cells (average of three experiments,
0.35   0.1) could be detected (Fig. 5, bottom). In contrast,
anti-Fas antibodies had no effect in  MT/lpr cultures,
which are deficient in functional Fas receptors. The addi-
tion of FasIg, a recombinant form of soluble Fas that is ca-
pable of binding FasL and neutralizing the Fas/FasL inter-
action (33), had no effect in either culture (Fig. 5, middle).
Thus, we conclude that isotype-switched B cell precursors
are susceptible to Fas-mediated deletion.
Blocking of the Fas/FasL Interaction In Vivo Allows De-
velopment of Isotype-switched B Cells in  MT Mice. To test
whether blocking the Fas/FasL interaction in vivo would
rescue isotype-switched B cell precursors, PLGA microcap-
sules containing recombinant FasIg were injected into
 MT mice. As described in Materials and Methods, these
capsules allowed continuous slow release of FasIg at a con-
stant amount of 10 ng/ml/day. 10 d after the last FasIg mi-
crocapsule injection, mice were tested for the presence of
mature B cells and antibody production. The results in Fig.
6 clearly show that inhibition of Fas/FasL interaction by
continuous presence of FasIg rescued isotype-switched B
cell precursors in  MT mice. Serum analysis revealed a
low, but significant amount of IgG production in  MT
mice treated with FasIg (Fig. 6 A). This was in contrast to
the control  MT mice, which fail to produce any serum
IgG. The presence of IgG in sera was confirmed by West-
ern blotting and independent detection of  H chain (Fig. 6
B). The specificity of the ELISA and the Western blot as-
says was confirmed and no reactivity was found between
the anti–mouse IgG reagent and human IgG or purified
FasIg (not depicted). Using an ELISPOT assay we were
able to detect low frequency of IgG-producing cells in the
FasIg-treated  MT mice (total of 10   4/spleen) relative
to control (Fig. 6 C). Finally, staining of spleen cells for  
and IgG expression revealed a very low population of ma-
ture, isotype-switched B cells in  MT mice treated with
FasIg (total of 1,750   585/spleen), but not in the control
 MT group (Fig. 6 D). Thus, administration of FasIg to
 MT mice rescues isotype-switched B cells from Fas-
mediated apoptosis allowing maturation and serum IgG
production in these mice, as confirmed by several experi-
mental techniques.
Developmental Pathway of Isotype-switched B Cell Precursors
Is T Cell Independent. To test for the role of T lympho-
cytes in regulating the developmental pathway of isotype-
switched B cell precursors, we crossed the Fas-deficient
 MT mice with mice deficient in TCR  and TCR . Re-
sults in Fig. 7 show that lack of T lymphocytes did not
abolish the development of isotype-switched B cells in
 MT/lpr mice. We found a low, but significant amount of
0.4–1.2 mg/ml IgG in serum samples collected from
 MT/lpr/TCR   /  mice at different ages (8–16 wk; Fig.
7 A). The presence of IgG in the serum was confirmed by
Western blotting (Fig. 7 C) and IgG-producing plasma cells
were visualized and quantitated at a significant frequency
by ELISPOT assay (Fig. 7, A and B). In addition, low
numbers of  -expressing cells are detected in  MT/lpr/
Figure 6. Blocking the Fas/FasL
interaction in vivo rescues isotype-
switched B cells in  MT mice. A
neutralizing recombinant FasIg protein
was purified and engineered into
slow releasing PLGA microcapsules.
The microcapsules were administered
to  MT mice by intramuscular injec-
tion of 10 mg/mouse every 10 d for
8 wk. Mice were first injected at 2
wk of age. Control  MT mice were
injected with empty microcapsules.
10 d after the last injection, mice
were killed. (A) Serum samples from
the mice were assayed for the presence
of IgG by ELISA. Results are mean  
SEM of three mice in each group.
(B) Detection of  H chain in serum
samples by Western blotting. Normal
serum sample dilution is 1:10. Samples
of   MT mice (control and FasIg-
treated) were not diluted. Purified
IgG was used as control. Line indicates
where irrelevant lane was removed
digitally. (C) Quantitation of IgG-
producing cells in spleens of  MT mice treated with FasIg relative to  MT and normal mice by ELISPOT. Representative ELISPOT membranes and
the calculated frequency of IgG-producing cells per 107 spleen cells are shown. Results are mean   SEM of three mice in each group. (D) FACS® analysis
for   and IgG expression. Spleen cells from the treated mice were stained for CD19, B220,  , and IgG. Analysis for   and IgG expression was performed
on 10,000 gated CD19 /B220  cells. The results shown are representative of eight injected mice in three different experiments.T
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TCR   /  spleens by flow cytometry (0.5–0.8%; unpub-
lished data). Furthermore, 2–3%  -expressing cells could
be detected in BM culture prepared from  MT/lpr/
TCR   /  mice (Fig. 7 D), frequencies that are similar to
those found in  MT and  MT/lpr BM cultures (Figs. 3
and 5). Thus, the developmental pathway and maturation
of isotype-switched B cell precursors is T cell independent.
However, because levels of serum IgG and frequency of
IgG-producing cells in the  MT/lpr/TCR   /  mice are
significantly reduced relative to the  MT/lpr mice, it is
possible that T lymphocytes are important in selection and
expansion of particular isotype-switched B cell clones, as
has been proposed (41).
Discussion
This study attempts to investigate the role of isotype
switching in promoting B cell development and its regula-
tion. The process of isotype switching has been linked, so
far, with mature B cell activation in response to T-depen-
dent antigens (1, 2, 5). Here we show for the first time that
isotype switching occurs normally during BM development
of B cell precursors and that development of these cells is
regulated by Fas signaling. Therefore, we suggest that an
alternative developmental pathway is used by isotype-
switched B cell precursors. The possibility that this path-
way is involved in B cell autoimmunity is discussed below.
In  MT mice, both V(D)J recombination and isotype
switching should occur to allow the development of ma-
ture, IgG-producing cells. Because V(D)J recombination
is not altered in  MT mice (28), there are two possible
explanations for lack of B cells in  MT mice: (a) B cell
precursors are not undergoing isotype switching, and (b)
isotype-switched B cells fail to develop and/or are nega-
tively selected. Recent studies have shown that isotype-
switched B cells can develop in  MT mice deficient of
functional Fas ( MT/lpr; reference 37), and development
of some IgA-secreting cells was evident in  MT mice re-
sponding to intestinal bacteria (42). By using our in vitro
culture system, here we show that isotype switching to
 H occurs in developing  MT B cell precursors as well as
in normal B cell precursors. The physiological relevance
of this phenomenon was further confirmed by detection
of ongoing isotype switching in developing B cells directly
in BM and not in the spleen of both  MT and normal
mice (Fig. 4 B). This suggests that spontaneous isotype
switching is restricted to developing B cells in the BM and
is not artificially induced in vitro. Ongoing class switching
was revealed at the RNA level by detection of AID IgG1
and IgG2b germline and postswitch transcripts (Fig. 4), all
evident for the occurrence of class switch recombination
(34). This is further confirmed by the detection of IgG-
expressing cells (Fig. 3) in the normal and the  MT cul-
tures. Detection of class switching in the normal cultures
and directly in the BM is important in linking the biolog-
ical and the physiological relevance of isotype switching to
normal B cell development, rather than to being artifi-
cially driven by the neo gene inserted into the  MT
mouse genome. In addition, under appropriate stimula-
tion, RAG    precursors have also been shown to un-
dergo isotype switching (43). What triggers isotype
switching in B cell precursors is unclear. It is tempting to
speculate that this process is T cell dependent. This possi-
bility is unlikely because B cells develop normally in T
cell–deficient mice (44) and only few T cell can be found
in our BM cultures ( 3%), and, as shown here, isotype-
Figure 7. Development of isotype-switched B cell precursors is T cell
independent. Normal,  MT,  MT/lpr, and  MT/lpr/TCR   /  mice
were analyzed for development of isotype-switched B cells and production
of serum IgG. (A) Titers of serum IgG were measured by ELISA (left) and
are expressed as milligram/milliliter. Frequency of IgG-producing cells in
spleens of these mice was quantitated by ELISPOT. The results are mean  
SEM of at least five mice in each group. (B) Representative ELISPOT
membrane. Frequencies of plasma cells are mean   SEM of at least five
mice in each group. (C) Detection of  H chain in serum samples by
Western blotting. Normal serum sample dilution is 1:10 and  MT/lpr
serum dilution is 1:20. Samples of  MT and  MT/lpr/TCR   /  are
not diluted. (D) Expression of  -expressing cells in  MT/lpr/TCR   / 
BM cultures. Cells grown in BM cultures prepared from the indicated
mice were stained for B220, CD19, and  . Analysis for   expression is
performed on 5,000 gated B220  cells.T
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switched B cells develop in  MT/lpr/TCR   /  mice.
Therefore, it is possible that isotype switching can occur
spontaneously in normal B cell development, as has been
described in several B cell lines and tumor cells (45),
though at a low frequency, as we show here. This may
suggest that  H-driven B cell development may have dif-
ferential regulation and/or tolerance requirement relative
to the well-described  H-driven development. One of
these differential regulations that we show here is the sen-
sitivity to Fas-mediated apoptosis.
How do we reconcile the facts that isotype switching
occurs in developing B cells, but these cells fail to mature
in  MT mice? One possible explanation is that  H fails to
promote B cell development and maturation (46). Data
collected from several  H Tg mice clearly showed that B
cell development and maturation and the establishment of
allelic exclusion are severely impaired (for review see ref-
erence 6). The inability of  H in supporting B cell devel-
opment may be attributable to isotype-specific differences
in membrane proximal regions and to stage-specific sig-
naling requirements (6, 47). An alternative explanation we
raise here is that isotype-switched B cells are negatively se-
lected in the BM. A possible mechanism of such negative
selection is apoptosis, induced by Fas signaling (17). The
data we present here clearly support this hypothesis,
showing that lack of Fas signaling rescues isotype-switched
B cell precursors in  MT/lpr mice, in  MT BM cultures
in vitro, and in mice injected with FasIg slow-releasing
microcapsules. Fas expression was detected in developing
BM B cells in vivo (39, 40) and in BM cultures in vitro
(Fig. 3), and activation of the Fas receptor resulted in in-
creased cell death (unpublished data) and elimination of
most of the Ig  cells in  MT cultures (Fig. 5). This is in
contrast to earlier studies, which failed to demonstrate a
role for Fas receptor in negative selection of self-reactive
Ig Tg B cell precursors in lpr mice (26, 48). Importantly,
B cell development in these Ig Tg mouse models is driven
by Tg  H, which may lead to Fas-independent pathway.
Interestingly, lack of Fas signaling in these mouse models
allowed the development of isotype-switched B cells se-
creting high titers of anti-DNA serum IgG (26). The abil-
ity of isotype-switched IgG-expressing B cells to develop
in these  H-Tg/lpr mice (26), as well as in  MT/lpr
mice (37), in  MT BM cultures, and in FasIg-treated
 MT mice, may suggest that  H can support B cell devel-
opment. However, as we show here, cells developing in
this pathway are sensitive to negative selection imposed by
Fas signaling.
Our interpretation of the results is illustrated in Fig. 8,
suggesting that different isotypic BCRs use different de-
velopmental pathways in B cell hematopoiesis. Most of B
cell development is driven by  H (Fig. 8 A; reference 13).
In this pathway, IgM-expressing immature B cells are sub-
jected to negative selection imposed by immune tolerance,
where both clonal deletion and receptor editing are major
mechanisms (9, 10). Data collected indicate that Ig -
driven B cell development and tolerance in the BM is Fas
independent (26, 48). However, upon maturation and pe-
ripheral activation, B cells express Fas and are sensitive to
Fas-mediated apoptosis. This has been attributed to newly
formed cells encountering self-antigens in the periphery
and to cells acquiring self-reactivity during the germinal
center reaction and somatic mutation (1, 16, 17). Such
cells undergo Fas-mediated apoptosis, but can be rescued
upon appropriate T cell help provided by CD40L (1). In
lpr mice, lack of Fas signaling promotes selection of au-
toreactive B cells (20–22), thereby implying a major role
of this molecule in maintaining peripheral tolerance. In
contrast, nonself–B cells undergo affinity maturation and
isotype switching to enter the memory long-lived com-
partment (1, 2, 5).
Isotype-switched B cells use the alternative develop-
mental pathway shown in this model (Fig. 8 B). Accord-
ingly, the  H-driven developmental pathway allows iso-
type-switched B cell precursors to develop directly into
the memory compartment as a result of the IgG isotypic
BCR. The validity of this developmental pathway is sup-
ported by earlier studies by Martin and Goodnow (3)
Figure 8. Suggested models for alternative developmental pathways
driven by different Ig heavy chain isotypes. The prevailing view of B cell
development is shown in A. Most of B cell development is driven by  H
chain, and IgM-expressing immature B cells are subjected to self-tolerance
in the BM. Mature peripheral B cells express IgM and IgD and become
activated upon encountering antigen. Published data suggest that peripheral
activation is an important checkpoint to extinguish self-reactivity, mediated
by lack of T cell help. In contrast, appropriate T cell help (such as CD40L
expression) promotes high affinity, nonself– B cells to develop in the germinal
center and undergo isotype switching and differentiate into the memory
compartment. The alternative developmental pathway of isotype-
switched B cell precursors is shown in B. According to this model, IgG
receptor drives IgG-expressing B cells directly into the memory compart-
ment. Because such development circumvents the requirement for peripheral
activation, it may confer severe autoimmune risk. In the normal (non-lpr)
mouse, such cells are negatively selected by the Fas pathway to prevent
their development into the memory compartment and participation in an
autoimmune response. Thus, the Fas/FasL pathway is a fail-safe mechanism
for elimination of isotype-switched B cell precursors and has a major role
in controlling autoimmunity during BM development.T
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showing that IgG membrane tail signaling directs IgG and
IgM/G-expressing cells into the memory compartment,
and that generation of memory B cells (49) and acquisition
of somatic mutations (21) can occur independently of ger-
minal center formation. Such cells accumulate in the MZ
subset in the spleen, as this subset contains many of the
memory B cells in immunized animals (6, 50). Our results
are in agreement with these studies by showing accumula-
tion of mature B cells expressing an MZ phenotype in
 MT/lpr mice because only isotype-switched B cells can
develop in mice carrying the  MT mutation. Also, mature
 MT/lpr B cells in spleen express relatively low levels of
BCR (Fig. 1 A and reference 37), a characteristic of iso-
type-switched memory B cells in normal mice in vivo (6,
50). Thus, isotype-switched B cell precursors can develop
directly into the memory compartment, effectively cir-
cumventing the requirement for peripheral activation.
Such a pathway confers severe autoimmune risk, as these
memory cells are not subjected to peripheral tolerance
mechanisms that are linked with activation (Fig. 8 A; ref-
erences 1, 16, and 17). In support of this are several studies
showing that tolerance is maintained in anti–self-IgM Tg
mice (10, 31), whereas autoantibodies are produced in
anti–self-IgG Tg mice (51, 52). However, as we show
here, Fas signaling strictly controls the development of
isotype-switched B cell precursors in non-Tg mice. We
believe that this negative selection aims to prevent the
generation of autoimmune memory B cell population
originating from isotype-switched B cell precursors, as Fas-
deficient  MT mice generate an autoimmune IgG reper-
toire (37). It is now interesting to find whether isotype-
switched B cell precursors undergo self-tolerance in the
BM, or perhaps are negatively selected regardless of their
BCR specificity. Such studies should consider the possibil-
ity that IgM- and IgG-expressing immature B cells might
have different signaling requirements for establishment of
tolerance (10, 31, 51, 52). Although it is clear from our
data that isotype switching occurs during B cell develop-
ment, we cannot exclude the possibility that self-reactivity
is promoted in the  MT/lpr mice because of peripheral
lymphopenia. This, however, does not exclude the role of
Fas in negative selection of isotype-switched B cells as we
show here in vivo and in vitro using Fas-sufficient mice.
Whether autoimmunity in the  MT/lpr mice is a result of
lymphopenia or a direct effect of Fas deficiency in selec-
tion of self-reactive clones is yet to be determined. It is
worth noting in this regard that at least with T lympho-
cytes, it is still unclear whether lymphopenia promotes au-
toimmunity or autoimmunity causes lymphopenia.
Although T lymphocytes are key regulators for the in-
duction of isotype switching in activated Ig  B cells (1, 2,
5), isotype switching in B cell precursors is T independent.
However, the low amounts of serum IgG and IgG-secret-
ing cells in  MT/lpr/TCR   /  mice suggest a role for T
lymphocytes in positive selection and expansion of isotype-
switched B cell clones (1). This is supported by several
studies showing that development of activated B cells into
the MZ and the memory compartment depends on proper
signaling and positive selection of high affinity clones (3,
11, 15, 53).
Finally, isotype-switched B cell precursors that circum-
vent limitation of tolerance may generate an autoimmune
memory repertoire as found in  MT/lpr mice and in anti–
self-IgG Tg mice (37, 51, 52). In the non-Tg mouse, the
development of these cells depends exclusively on lack of
Fas functionality (37). Recent data suggest an additional
role of Fas signaling in promoting selection and activation
of self-reactive cells and in memory formation (21–23). If
not deleted, such as in mice carrying lpr or gld (nonfunc-
tional FasL) mutations, isotype-switched B cells may de-
velop into the memory compartment. In a T-dependent
response, these cells can be positively selected and activated
to participate in B cell autoimmunity. Hence, although Fas
functionality in controlling mature B cell activation and
tolerance is well described, this study implies a major role
for this pathway in negative selection and in controlling au-
toimmunity at early stages of B cell development.
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